We are live on ! Find out more
Goldman Sachs

Goldman Sachs Portfolio holdings

AUM $871B
1-Year Est. Return 31.28%
 

Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.

This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+31.28%
3 Year Est. Return
+94.73%
5 Year Est. Return
+114.04%
10 Year Est. Return
+476.55%
AUM
$471B
AUM Growth
+$25.1B
Cap. Flow
+$36.8B
Cap. Flow %
7.8%
Top 10 Hldgs %
18.87%
Holding
6,784
New
621
Increased
2,690
Reduced
2,234
Closed
596

Sector Composition

Rank Sector Weight
1 Technology 15.7%
2 Consumer Discretionary 9.53%
3 Financials 8.37%
4 Healthcare 7.77%
5 Communication Services 6.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALR
5901
DELISTED
AlerisLife Inc
ALR
$66K ﹤0.01%
15,036
-22,913
-60% -$109K
FTEV.WS
5902
DELISTED
FinTech Evolution Acquisition Group Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share for $11.50 per share
FTEV.WS
$66K ﹤0.01%
98,568
NAUT icon
5903
Nautilus Biotechnolgy
NAUT
$129M
$64K ﹤0.01%
+10,423
New +$83.1K
HUGS.WS
5904
DELISTED
USHG Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
HUGS.WS
$64K ﹤0.01%
75,040
LHC.WS
5905
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$64K ﹤0.01%
100,667
HCWB icon
5906
HCW Biologics
HCWB
$5.83M
$63K ﹤0.01%
+82
New +$86.3K
CSCI
5907
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$63K ﹤0.01%
845
-826
-49% -$58.7K
VELOW
5908
DELISTED
Velocity Acquisition Corp. Warrant
VELOW
$63K ﹤0.01%
90,027
-2,638
-3% -$2.36K
FMAC.WS
5909
DELISTED
FirstMark Horizon Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one shar
FMAC.WS
$63K ﹤0.01%
50,000
SPAQ.WS
5910
DELISTED
Spartan Acquisition Corp. III Warrants, exercisable for one share of Class A Common Stock
SPAQ.WS
$63K ﹤0.01%
57,572
-113,678
-66% -$133K
AFI
5911
DELISTED
Armstrong Flooring, Inc.
AFI
$62K ﹤0.01%
19,762
-10,461
-35% -$43K
DAVEW icon
5912
Dave Inc Warrants
DAVEW
$38.3M
$61K ﹤0.01%
35,662
-35,400
-50% -$58.8K
IRON icon
5913
Disc Medicine
IRON
$3.01B
$60K ﹤0.01%
497
+61
+14% +$8.34K
SDAWW
5914
SunCar Technology Group Warrant
SDAWW
$60K ﹤0.01%
250,000
LFWD icon
5915
ReWalk Robotics
LFWD
$20.3M
$60K ﹤0.01%
476
-194
-29% -$24.1K
SLGCW
5916
DELISTED
SomaLogic, Inc. Warrant
SLGCW
$60K ﹤0.01%
+17,364
New +$53.5K
TIO
5917
DELISTED
Tingo Group, Inc. Common Stock
TIO
$59K ﹤0.01%
37,976
-121,168
-76% -$225K
BCLI
5918
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$58K ﹤0.01%
1,173
-2,672
-69% -$141K
CBIO
5919
Crescent Biopharma
CBIO
$588M
$58K ﹤0.01%
264
-970
-79% -$205K
NERV icon
5920
Minerva Neurosciences
NERV
$191M
$58K ﹤0.01%
4,195
-8,001
-66% -$120K
YARW
5921
Yarrow Bioscience, Inc. Common Stock
YARW
$25.6M
$58K ﹤0.01%
47
+3
+7% +$5.82K
ANAC.WS
5922
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$58K ﹤0.01%
78,750
BYFC icon
5923
Broadway Financial
BYFC
$101M
$57K ﹤0.01%
+2,139
New +$56.2K
GALT icon
5924
Galectin Therapeutics
GALT
$192M
$57K ﹤0.01%
14,717
-3,458
-19% -$11.7K
TRAW icon
5925
Traws Pharma
TRAW
$8.36M
$57K ﹤0.01%
+596
New +$76.8K

Similar funds

Goldman Sachs's Q3 2021 Portfolio in Review

As of Q3 2021, Goldman Sachs held 6,784 positions worth $471B, up 5.6% from $446B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Goldman Sachs deployed $36.8B of net new capital in Q3 2021, opening 621 new positions and adding to 2,690 existing holdings. Its largest new stake was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $928M trimmed.

  • Goldman Sachs's largest Q3 2021 buy was Sterling Check Corp. Common Stock: 59,953,230 shares worth $1.56B.
  • Goldman Sachs added most to Alibaba in Q3 2021, an estimated $3.18B increase.
  • Goldman Sachs's biggest Q3 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $928M.
  • Goldman Sachs fully exited Brookfield Property Partners L.P. Limited Partnership Units in Q3 2021, selling an estimated $327M.
  • Goldman Sachs's ten largest holdings make up 19% of its $471B portfolio in Q3 2021.
  • Goldman Sachs opened 621 new positions and closed 596 in Q3 2021.
  • Goldman Sachs's portfolio value rose 5.6% quarter-over-quarter to $471B.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.